<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Empire Stock Transfer using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2012. www.edgarsuite.com -->
<xbrl xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2012-01-31' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:fil='http://www.gaiaremedies.com/20120930' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:dei='http://xbrl.sec.gov/dei/2012-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:iso4217='http://www.xbrl.org/2003/iso4217'>
	<link:schemaRef xlink:type='simple' xlink:href='gair-20120930.xsd' />
	<dei:DocumentType contextRef='Y12Q3'>10-Q</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='Y12Q3'>2012-09-30</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='Y12Q3'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='Y12Q3'>GAIA REMEDIES, INC.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='Y12Q3'>0001522787</dei:EntityCentralIndexKey>
	<dei:CurrentFiscalYearEndDate contextRef='Y12Q3'>--03-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityFilerCategory contextRef='Y12Q3'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='Y12Q3'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='Y12Q3'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='Y12Q3'>Yes</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='Y12Q3'>2013</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='Y12Q3'>Q2</dei:DocumentFiscalPeriodFocus>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='E12Q3' unitRef='Shares'>5557500</dei:EntityCommonStockSharesOutstanding>
	<us-gaap:Cash decimals='INF' contextRef='E12Q3' unitRef='USD'>1571</us-gaap:Cash>
	<us-gaap:Cash decimals='INF' contextRef='E12Q1' unitRef='USD'>12686</us-gaap:Cash>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E12Q3' unitRef='USD'>1571</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E12Q1' unitRef='USD'>12686</us-gaap:AssetsCurrent>
	<us-gaap:Assets decimals='INF' contextRef='E12Q3' unitRef='USD'>1571</us-gaap:Assets>
	<us-gaap:Assets decimals='INF' contextRef='E12Q1' unitRef='USD'>12686</us-gaap:Assets>
	<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent decimals='INF' contextRef='E12Q3' unitRef='USD'>750</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E12Q3' unitRef='USD'>750</us-gaap:LiabilitiesCurrent>
	<us-gaap:Liabilities decimals='INF' contextRef='E12Q3' unitRef='USD'>750</us-gaap:Liabilities>
	<us-gaap:CommitmentsAndContingencies contextRef='E12Q3' unitRef='USD' xsi:nil='true' />
	<us-gaap:CommitmentsAndContingencies contextRef='E12Q1' unitRef='USD' xsi:nil='true' />
	<us-gaap:CommonStockValue decimals='INF' contextRef='E12Q3' unitRef='USD'>5558</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E12Q1' unitRef='USD'>5558</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E12Q3' unitRef='USD'>40992</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E12Q1' unitRef='USD'>40992</us-gaap:AdditionalPaidInCapital>
	<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage decimals='INF' contextRef='E12Q3' unitRef='USD'>-45729</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
	<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage decimals='INF' contextRef='E12Q1' unitRef='USD'>-33864</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E12Q3' unitRef='USD'>821</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E12Q1' unitRef='USD'>12686</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E12Q3' unitRef='USD'>1571</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E12Q1' unitRef='USD'>12686</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E12Q3' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E12Q1' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E12Q3' unitRef='Shares'>100000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E12Q1' unitRef='Shares'>100000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E12Q3' unitRef='Shares'>5557500</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E12Q1' unitRef='Shares'>5557500</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E12Q3' unitRef='Shares'>5557500</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E12Q1' unitRef='Shares'>5557500</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='Y12Q3' unitRef='USD'>3088</us-gaap:ProfessionalFees>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='Y11Q3' unitRef='USD'>4781</us-gaap:ProfessionalFees>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='D120401_120930' unitRef='USD'>9216</us-gaap:ProfessionalFees>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='D110401_110930' unitRef='USD'>19085</us-gaap:ProfessionalFees>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='D101215_120930' unitRef='USD'>38484</us-gaap:ProfessionalFees>
	<us-gaap:OtherExpenses decimals='INF' contextRef='Y12Q3' unitRef='USD'>1461</us-gaap:OtherExpenses>
	<us-gaap:OtherExpenses decimals='INF' contextRef='Y11Q3' unitRef='USD'>1338</us-gaap:OtherExpenses>
	<us-gaap:OtherExpenses decimals='INF' contextRef='D120401_120930' unitRef='USD'>2649</us-gaap:OtherExpenses>
	<us-gaap:OtherExpenses decimals='INF' contextRef='D110401_110930' unitRef='USD'>2407</us-gaap:OtherExpenses>
	<us-gaap:OtherExpenses decimals='INF' contextRef='D101215_120930' unitRef='USD'>7245</us-gaap:OtherExpenses>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y12Q3' unitRef='USD'>4549</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y11Q3' unitRef='USD'>6119</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D120401_120930' unitRef='USD'>11865</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D110401_110930' unitRef='USD'>21492</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D101215_120930' unitRef='USD'>45729</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y12Q3' unitRef='USD'>-4549</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y11Q3' unitRef='USD'>-6119</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D120401_120930' unitRef='USD'>-11865</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D110401_110930' unitRef='USD'>-21492</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D101215_120930' unitRef='USD'>-45729</us-gaap:NetIncomeLoss>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y12Q3' unitRef='UsdPerShare'>0.00</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y11Q3' unitRef='UsdPerShare'>0.00</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D120401_120930' unitRef='UsdPerShare'>0.00</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D110401_110930' unitRef='UsdPerShare'>0.00</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y12Q3' unitRef='Shares'>5557500</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y11Q3' unitRef='Shares'>5557500</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D120401_120930' unitRef='Shares'>5557500</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D110401_110930' unitRef='Shares'>5557500</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:ProfitLoss decimals='INF' contextRef='D120401_120930' unitRef='USD'>-11865</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='INF' contextRef='D110401_110930' unitRef='USD'>-21492</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='INF' contextRef='D101215_120930' unitRef='USD'>-45729</us-gaap:ProfitLoss>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D120401_120930' unitRef='USD'>750</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D110401_110930' unitRef='USD'>1948</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D101215_120930' unitRef='USD'>750</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D120401_120930' unitRef='USD'>-11115</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D110401_110930' unitRef='USD'>-19544</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D101215_120930' unitRef='USD'>-44979</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF' contextRef='D101215_120930' unitRef='USD'>46550</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D101215_120930' unitRef='USD'>46550</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashPeriodIncreaseDecrease decimals='INF' contextRef='D120401_120930' unitRef='USD'>-11115</us-gaap:CashPeriodIncreaseDecrease>
	<us-gaap:CashPeriodIncreaseDecrease decimals='INF' contextRef='D110401_110930' unitRef='USD'>-19544</us-gaap:CashPeriodIncreaseDecrease>
	<us-gaap:CashPeriodIncreaseDecrease decimals='INF' contextRef='D101215_120930' unitRef='USD'>1571</us-gaap:CashPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E12Q1' unitRef='USD'>12686</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E11Q1' unitRef='USD'>41822</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E11Q3' unitRef='USD'>22278</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E12Q3' unitRef='USD'>1571</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:InterestPaid contextRef='D120401_120930' unitRef='USD' xsi:nil='true' />
	<us-gaap:InterestPaid contextRef='D110401_110930' unitRef='USD' xsi:nil='true' />
	<us-gaap:InterestPaid contextRef='D101215_120930' unitRef='USD' xsi:nil='true' />
	<us-gaap:IncomeTaxesPaid contextRef='D120401_120930' unitRef='USD' xsi:nil='true' />
	<us-gaap:IncomeTaxesPaid contextRef='D110401_110930' unitRef='USD' xsi:nil='true' />
	<us-gaap:IncomeTaxesPaid contextRef='D101215_120930' unitRef='USD' xsi:nil='true' />
	<us-gaap:NatureOfOperations contextRef='Y12Q3'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 1 - NATURE OF BUSINESS&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Nature of Business&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Gaia Remedies, Inc. (&amp;#147;Gaia&amp;#148; or the &amp;#147;Company&amp;#148;) was incorporated in Nevada on December 15, 2010. Gaia is in the business of the online retail sale of all natural pet remedies. Gaia is a development stage company and has not yet realized any revenues from its planned or any other operations.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;The accompanying unaudited interim financial statements have been prepared by the Company pursuant to the rules and regulations of the United States Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the Company&amp;#146;s Annual Report on Form 10-K. &amp;#160;Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included.&amp;#160; Such adjustments consist of normal recurring adjustments. Operating results for the six months ended September 30, 2012 are not necessarily indicative of the results that may be expected for the full year ending March 31, 2013.&lt;/p&gt;</us-gaap:NatureOfOperations>
	<us-gaap:LiquidityDisclosureGoingConcernNote contextRef='Y12Q3'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 2 - GOING CONCERN&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Gaia has a net loss and has a deficit accumulated during the development stage of $45,729 as of September 30, 2012.&amp;#160; Gaia&apos;s financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.&amp;#160; However, Gaia has no current source of revenue, which raises substantial doubt about the Company&amp;#146;s ability to continue as a going concern. Without realization of additional capital, it would be unlikely for Gaia to continue as a going concern.&amp;#160; Gaia&amp;#146;s management plans on raising cash from public or private debt or equity financing, on an as needed basis and in the longer term, revenues from the operations of its online retail business. Gaia&amp;#146;s ability to continue as a going concern is dependent on these additional cash financings, and, ultimately, upon achieving profitable operations through the operation of its online retail business or otherwise. &lt;/p&gt;</us-gaap:LiquidityDisclosureGoingConcernNote>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef='Y12Q3'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 3 - ADVANCE FROM SHAREHOLDER&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;A shareholder of the Company has offered a shareholder loan facility up to $100,000.&amp;#160; The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013. As of September 30, 2012, the amount outstanding under the shareholder loan facility was $ nil. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E12Q3' unitRef='USD'>45729</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:LineOfCreditFacilityDescription contextRef='D121001_130630'>A shareholder of the Company has offered a shareholder loan facility up to $100,000. The loan facility is unsecured and bears interest at 5% per annum and is payable on demand after June 30, 2013</us-gaap:LineOfCreditFacilityDescription>
	<context id='Y12Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<startDate>2012-07-01</startDate>
			<endDate>2012-09-30</endDate>
		</period>
	</context>
	<context id='E12Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<instant>2012-09-30</instant>
		</period>
	</context>
	<context id='E12Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<instant>2012-03-31</instant>
		</period>
	</context>
	<context id='Y11Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<startDate>2011-07-01</startDate>
			<endDate>2011-09-30</endDate>
		</period>
	</context>
	<context id='D120401_120930'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<startDate>2012-04-01</startDate>
			<endDate>2012-09-30</endDate>
		</period>
	</context>
	<context id='D110401_110930'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<startDate>2011-04-01</startDate>
			<endDate>2011-09-30</endDate>
		</period>
	</context>
	<context id='D101215_120930'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<startDate>2010-12-15</startDate>
			<endDate>2012-09-30</endDate>
		</period>
	</context>
	<context id='E11Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<instant>2011-03-31</instant>
		</period>
	</context>
	<context id='E11Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<instant>2011-09-30</instant>
		</period>
	</context>
	<context id='D121001_130630'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001522787</identifier>
		</entity>
		<period>
			<startDate>2012-10-01</startDate>
			<endDate>2013-06-30</endDate>
		</period>
	</context>
	<unit id='Shares'>
		<measure>shares</measure>
	</unit>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>shares</measure>
			</unitDenominator>
		</divide>
	</unit>
</xbrl>
